NetraMark Holdings (XCNQ:AIAI) Change In Receivables : C$-0.13 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Change In Receivables?

NetraMark Holdings's change in receivables for the quarter that ended in Mar. 2024 was C$-0.15 Mil. It means NetraMark Holdings's Accounts Receivable increased by C$0.15 Mil from Dec. 2023 to Mar. 2024 .

NetraMark Holdings's change in receivables for the fiscal year that ended in Sep. 2023 was C$0.17 Mil. It means NetraMark Holdings's Accounts Receivable declined by C$0.17 Mil from Sep. 2022 to Sep. 2023 .

NetraMark Holdings's Accounts Receivable for the quarter that ended in Mar. 2024 was C$0.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NetraMark Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 69.88.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NetraMark Holdings's liquidation value for the three months ended in Mar. 2024 was C$0.12 Mil.

NetraMark Holdings Change In Receivables Historical Data

The historical data trend for NetraMark Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Change In Receivables Chart

NetraMark Holdings Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Change In Receivables

-0.03

-0.32

0.09

0.17

NetraMark Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial										0.19	-	-	0.03	-0.15

NetraMark Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.13 Mil.

NetraMark Holdings (XCNQ:AIAI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NetraMark Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.17	/	0.222	*	91
=	69.88

2. In Ben Graham's calculation of liquidation value, NetraMark Holdings's accounts receivable are only considered to be worth 75% of book value:

NetraMark Holdings's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.26	-	0.263	+	0.75 * 0.17	+	0.5 * 0
=	0.12

NetraMark Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

NetraMark Holdings (XCNQ:AIAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

AINMF:USA

Address

1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1

Website

https://www.nurosene.com

NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.

Executives

Andrew Parks

Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines